Henley Finance, Ltd. v. Goyette & Assoc., Inc.

District Court, E.D. California·Decided February 28, 2022·No. 2:20-cv-01834·Unknown

Opinion

Plaintiff, No. 2:20-cv-01834-TLN-KJN

v. ORDER GOYETTE & ASSOCIATES, INC., a California corporation; BIOSCIENCE ENTERPRISES, INC., a California corporation; and DOES 1-20, inclusive, Defendants,

This matter is before the Court on Defendants Goyette & Associates, Inc. (“Goyette”) and Bioscience Enterprises, Inc.’s (“Bioscience”) (collectively, “Defendants”) Motions to Dismiss. (ECF Nos. 11, 10.) Plaintiff Henley Finance, Ltd. (“Plaintiff”) opposes Defendants’ motions. (ECF Nos. 12, 13.) For the reasons set forth below, the Court DENIES Defendants’ motions. (ECF Nos. 11, 10.) /// /// /// /// I. FACTUAL AND PROCEDURAL BACKGROUND1 Plaintiff brings this action against Defendants alleging the following: (1) conversion of funds; (2) breach of contract; and (3) breach of fiduciary duty. (See ECF No. 1.) Plaintiff is a foreign finance “company incorporated in England and Wales.” (Id. at 2.) Goyette is a California corporation, allegedly providing services including business advice, legal services, and escrow services. (Id.) Biosciences is a Delaware corporation with its principal place of business in California. (Id. at 3.) A non-party Robert Kay (“Kay”), a resident of England, was allegedly interested in investing in the “CBD/Hemp trade.” (Id. at 4.) On March 15, 2019, Kay’s purported first investment in the industry was in Commodity Clearinghouse Corporation (“Commodity”) in California, in the sum of $30,000. (Id.) In completing the transaction, the money was first transferred to an escrow account organized by Goyette. (Id. at 5.) From July to September 2019, Kay was allegedly physically present at a “Bioscience/[Commodity] office” in California, where he “met with and came to know” Bioscience’s principal executive officer. (Id. at 6.) Bioscience’s principal executive officer and Kay purportedly discussed that Kay “had a business relationship with [Plaintiff]” and “a relationship of trust and confidence with [Plaintiff]’s founder.” (Id. at 6.) Bioscience’s principal executive officer requested Kay introduce him to Plaintiff’s founder “to discuss Bioscience obtaining short term financing,” and Kay purportedly obliged. (Id.) On July 2, 2019, Plaintiff and Bioscience entered into a loan agreement whereby Plaintiff agreed to make a short-term loan to Bioscience. (Id. at 8.) The term of the loan agreement commenced on the date the loan funds were transmitted from Plaintiff to Bioscience. (Id.) The term of the loan agreement was to end no earlier than thirty days from Bioscience’s receipt of the funds and no later than sixty days after Bioscience’s receipt of funds (anticipated by September 3, 2019). (Id.) Goyette allegedly agreed to provide escrow services for the Plaintiff-Bioscience loan. 1 The following of recitation of facts is taken, sometimes verbatim, from Plaintiff’s Complaint. (ECF No. 1.) (Id.) Plaintiff alleges Defendants agreed the funds in the escrow account would not leave the escrow account “except on the terms as required under the loan agreement and as instructed by [Plaintiff].” (Id.) On July 10, 2019, Plaintiff transferred $999,995 to the Goyette escrow account. (Id.) On July 11, 2019, Kay, acting as Plaintiff’s authorized agent, called and spoke with Goyette. (Id. at 9.) Goyette allegedly confirmed to Kay that the funds had been received and that the funds were not to be distributed without the express permission of Richard Butler (“Butler”), Plaintiff’s founder and authorized agent. (Id. at 6, 9.) Additionally, Plaintiff alleges Bioscience’s principal executive officer wrote to Goyette on September 7, 2019, indicating that none of Plaintiff’s funds were to be used without the express written authorization of Butler. (Id. at 9.) Plaintiff alleges Goyette disbursed Plaintiff’s funds to Bioscience (and allegedly others, though there is no mention to whom) without the express authorization of Butler. (Id.) Further, Goyette allegedly disbursed $5,000 of Plaintiff’s funds to itself without Butler’s authorization. (Id.) Plaintiff alleges Defendants have not returned any funds to Plaintiff to date. (Id. at 10.) Plaintiff filed its Complaint on September 11, 2020, seeking compensatory damages through three causes of action: (1) conversion of funds; (2) breach of contract; and (3) breach of fiduciary duty. (Id. at 10–12.) Goyette filed a motion to dismiss on November 11, 2020, pursuant to Federal Rules of Civil Procedure (“Rule” or “Rules”) 12(b)(1) and 12(b)(6). (ECF No. 11.) Bioscience separately filed a motion to dismiss on November 11, 2020, pursuant to 12(b)(1). (ECF No. 10.) On December 23, 2020, Plaintiff opposed Defendants’ motions. (ECF Nos. 12, 13.) Goyette filed a reply on December 30, 2020, and Bioscience filed a reply on December 31, 2020. (ECF Nos. 14, 16.) A. Federal Rule of Civil Procedure 12(b)(1) A motion under Rule 12(b)(1) challenges a federal court's jurisdiction to decide claims alleged in the complaint. Fed. R. Civ. P. 12(b)(1); see also id. at 12(h)(3) (“If the court determines at any time that it lacks subject-matter jurisdiction, the court must dismiss the action.”); Robinson v. United States, 586 F.3d 683, 685 (9th Cir. 2009) (holding the court may determine jurisdiction on a Rule 12(b)(1) motion unless “the jurisdictional issue is inextricable from the merits of a case”) (internal citations omitted). A Rule 12(b)(1) motion attacking subject matter jurisdiction may be either facial or factual. White v. Lee, 227 F.3d 1214, 1242 (9th Cir. 2000). When the motion is a facial attack, the court only considers the allegations in the complaint and any documents attached to the complaint or referred to in the complaint. Gould Electronics Inc. v. U.S., 220 F.3d 169, 176 (3rd Cir. 2000). The court accepts all the material factual allegations in plaintiff’s complaint as true. Cahill v. Liberty Mut. Ins. Co., 80 F.3d 336, 337–38 (9th Cir. 1996). “[J]urisdiction must be shown affirmatively, and that showing cannot be made by drawing from the pleadings inferences favorable to the party asserting it.” Shipping Financial Services Corp. v. Drakos, 140 F.3d 129, 131 (2nd Cir. 1998) (citing Norton v. Larney, 266 U.S. 511, 515 (1925)). When a Rule 12(b)(1) motion attacks the existence of subject matter jurisdiction “in fact,” no presumption of truthfulness attaches to the plaintiff’s allegations. Thornhill Pub. Co., Inc. v. Gen. Tel. & Elecs. Corp., 594 F.2d 730, 733 (9th Cir. 1979). Rather, “the district court is not restricted to the face of the pleadings, but may review any evidence, such as affidavits and testimony, to resolve factual disputes concerning the existence of jurisdiction.” McCarthy v. United States, 850 F.2d 558, 560 (9th Cir. 1988). “Once challenged, the party asserting subject matter jurisdiction has the burden of proving its existence.” Robinson, 586 F.3d at 685 (quoting Rattlesnake Coal. v. E.P.A., 509 F.3d 1095, 1102 n.1 (9th Cir. 2007)). B. Federal Rule of Civil Procedure 12(b)(6) A motion to dismiss for failure to state a claim upon which relief can be granted under

Henley Finance, Ltd. v. Goyette & Assoc., Inc., (E.D. Cal. 2022).

Henley Finance, Ltd. v. Goyette & Assoc., Inc. (Henley Finance, Ltd. v. Goyette & Assoc., Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Norton v. Larney
266 U.S. 511 (Supreme Court, 1925)
Cruz v. Beto
405 U.S. 319 (Supreme Court, 1972)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Swierkiewicz v. Sorema N. A.
534 U.S. 506 (Supreme Court, 2002)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Mindys Cosmetics, Inc. v. Dakar
611 F.3d 590 (Ninth Circuit, 2010)
Daniels-Hall v. National Education Ass'n
629 F.3d 992 (Ninth Circuit, 2010)
Richard McCarthy v. United States
850 F.2d 558 (Ninth Circuit, 1988)
United States v. Pablo Mayans
17 F.3d 1174 (Ninth Circuit, 1994)